Original article by Paul Garvey. Bridget Carter
The Australian – Page: 19 & 22 : 2-Jun-16
Shares in Australian-listed ALS went into a trading halt on 1 June 2016, ahead of an announcement about a potential buyout. Media reports have suggested that private equity firms Bain Capital and Advent International have approached the mining services group regarding a takeover bid. ALS shares last traded at $A4.05, having peaked at more than $A10 in 2013. The laboratory testing group’s net loss widened to $A240.7 million in the year to 31 March 2016.
CORPORATES
ALS LIMITED – ASX ALQ. BAIN CAPITAL LLC. ADVENT INTERNATIONAL CORPORATION. BANK OF AMERICA AUSTRALIA LIMITED. MERRILL LYNCH (AUSTRALIA) PTY LTD. JP MORGAN AUSTRALIA LIMITED. THE GOLDMAN SACHS GROUP INCORPORATED. SGS LIMITED. ISATEC LIMITED. BUREAU VERITAS. CRESCENT CAPITAL PARTNERS LIMITED. CARDNO LIMITED – ASX CDD. BRADKEN LIMITED – ASX BKN. MOLY-COP. ARRIUM LIMITED – ASX ARI. TPG CAPITAL LP. THE BLACKSTONE GROUP LP. RHONE CAPITAL LLC. BOART LONGYEAR LIMITED – ASX BLY. CENTERBRIDGE PARTNERS LP